2Sacco RL,Rcberts JK,Jacobs B.lHomocysteiae as a risk factor for ischemic stroke.An epidemiological atudly in evolution[J].Nenoepidemiolo,1998,17(4):167-173.
3Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease:implications for patient selection. Circulation, 1990,82 (6): 1193-1021
4Zwaka TP, Hombach V,Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis. Circulation. 2001,103 (6): 1194-1197
5Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 1999,99 (4) :855-860
6Demosthenes K, Socrates K, Eleftherios G, et al. C-reactive protein concentrations and angiographic characteristics of coronary lesions.Clin Chem,2001,47 (2): 882-886
7SaccoRL,Roberts JK,Jacobs BS.Homocysteine as a risk factor for ischemic stroke:An epidemiological study in evolution.Neuroepidemiology.1998,17:167.
8Refsum H,Ueland PM,Nygard O,et al.Homocysteine and cardiovascular diseases.Annu Rev Med.1998,49:31.
9Tawakol A,Omland T,Gerhard M,et al.Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans.Circulation.1997,95:1119.
10George N,Nelch.Joseph loscaizo:Homocysteine and atherothrombosis.N Engl J Med.1998,338(15):1042.
